Obesity, characterized by excessive accumulation of body fat, is associated with reduced vitamin D levels. Several polymorphisms of the vitamin D receptor exist, such as TaqI (rs731236), although their association with obesity remains inconsistent. The aim of this study was to evaluate the effect of TaqI polymorphism on biomarkers in individuals with obesity. The study has been approved by the Research Ethics Committee of the Federal University of Pampa (UNIPAMPA), under approval number 5.308.525. A total of 275 individuals were included in the study, divided into groups according to Body Mass Index: eutrophic, overweight, and individuals with obesity. Blood samples and anthropometric data were collected for analysis and 246 individuals were genotyped for the VDR gene TaqI polymorphism. Results showed that vitamin D levels were higher in individuals with CC genotype compared with those with TT genotype. A decrease in biochemical parameter levels was observed in the obesity group. In contrast, inflammatory and oxidative stress markers were increased in the overweight and obesity groups. Additionally, TBARS, IL-8, IL-10, and CRP were identified as independent risk factors for obesity, where vitamin D was identified as an independent protective factor. Although TaqI polymorphism was not an independent risk factor for obesity, our results emphasize the relevance of inflammatory and oxidative stress biomarkers in obesity risk assessment. Moreover, the modulation of vitamin D levels by genotype reinforces its potential as a target for preventive and therapeutic interventions due to its protective role.
The present work carried out the quantification of total polyphenols in the aqueous extract of the leaves of Aloysia gratissima, and its oral absorption index in Wistar rats. For this, 20 adult rats were divided into five treatment groups: saline solution; 100 mg/Kg of A. gratissima extract; 50 mg/Kg and 100 mg/Kg of rutin and co-treatment with 50 mg/Kg of extract and 10 mg/Kg of rutin, performed orally for 14 days. For the quantification of total polyphenols, the Folin Ciocalteau method was used. In the extract, the concentration of total polyphenols was 7.11 mg GAE/mL, in the plasma of control animals the baseline level was 4.3 mg GAE/mL. In the treated groups, significantly higher values were observed, of 9.32 mg GAE/mL, 6.65 mg GAE/mL, 8.34 mg GAE/mL and 10.14 mg GAE/mL, respectively. Such data configure A. gratissima as a good source for obtaining total polyphenols due both to its high concentration in the extract and also to their good bioavailability.